Literature DB >> 23408692

Molecular characterization of Streptococcus pneumoniae serotype 12F isolates associated with rural community outbreaks in Alaska.

Tammy Zulz1, Jay D Wenger, Karen Rudolph, D Ashley Robinson, Alexey V Rakov, Dana Bruden, Rosalyn J Singleton, Michael G Bruce, Thomas W Hennessy.   

Abstract

Outbreaks of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae serotype 12F were observed in two neighboring regions of rural Alaska in 2003 to 2006 and 2006 to 2008. IPD surveillance data from 1986 to 2009 and carriage survey data from 1998 to 2004 and 2008 to 2009 were reviewed to identify patterns of serotype 12F transmission. Pulsed-field gel electrophoresis was performed on all available isolates, and selected isolates were characterized by additional genetic subtyping methods. Serotype 12F IPD occurred in two waves in Alaska between 1986 and 2008. While cases of disease occurred nearly every year in Anchorage, in rural regions, 12F IPD occurred with rates 10- to 20-fold higher than those in Anchorage, often with many years between disease peaks and generally caused by a single predominant genetic clone. Carriage occurred predominantly in adults, except early in the rural outbreaks, when most carriage was in persons <18 years old. In rural regions, carriage of 12F disappeared completely after outbreaks. Different 12F clones appear to have been introduced episodically into rural populations, spread widely in young, immunologically naïve populations (leading to outbreaks of IPD lasting 1 to 3 years), and then disappeared rapidly from the population. Larger population centers might have been the reservoir for these clones. This epidemiologic pattern is consistent with a highly virulent, but immunogenic, form of pneumococcus.

Entities:  

Mesh:

Year:  2013        PMID: 23408692      PMCID: PMC3647894          DOI: 10.1128/JCM.02880-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

Review 1.  Effective management in clusters of pneumococcal disease: a systematic review.

Authors:  Marina Basarab; Chikwe Ihekweazu; Robert George; Richard Pebody
Journal:  Lancet Infect Dis       Date:  2011-02       Impact factor: 25.071

2.  Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults.

Authors:  Rosalyn J Singleton; Jay C Butler; Lisa R Bulkow; Debby Hurlburt; Katherine L O'Brien; William Doan; Alan J Parkinson; Thomas W Hennessy
Journal:  Vaccine       Date:  2006-12-11       Impact factor: 3.641

3.  Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage.

Authors:  Daniel M Weinberger; Ron Dagan; Noga Givon-Lavi; Gili Regev-Yochay; Richard Malley; Marc Lipsitch
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

4.  Recommended adult immunization schedule--United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-02-04       Impact factor: 17.586

5.  Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity.

Authors:  Thomas W Hennessy; Rosalyn J Singleton; Lisa R Bulkow; Dana L Bruden; Debby A Hurlburt; Debra Parks; Matthew Moore; Alan J Parkinson; Anne Schuchat; Jay C Butler
Journal:  Vaccine       Date:  2005-09-12       Impact factor: 3.641

Review 6.  Epidemiological differences among pneumococcal serotypes.

Authors:  William P Hausdorff; Daniel R Feikin; Keith P Klugman
Journal:  Lancet Infect Dis       Date:  2005-02       Impact factor: 25.071

7.  Outbreak of invasive pneumococcal disease--Alaska, 2003-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-01-28       Impact factor: 17.586

8.  Impact of a mass immunization campaign to control an outbreak of severe respiratory infections in Nunavik, northern Canada.

Authors:  Abdoul Aziz Ndiaye; Philippe De Wals; Jean-François Proulx; Manale Ouakki; Louise Jetté; Serge Déry
Journal:  Int J Circumpolar Health       Date:  2006-09       Impact factor: 1.228

9.  Invasive pneumococcal disease in Alaskan children: impact of the seven-valent pneumococcal conjugate vaccine and the role of water supply.

Authors:  Jay D Wenger; Tammy Zulz; Dana Bruden; Rosalyn Singleton; Michael G Bruce; Lisa Bulkow; Debbie Parks; Karen Rudolph; Debby Hurlburt; Troy Ritter; Joseph Klejka; Thomas Hennessy
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

10.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

View more
  9 in total

1.  Serotypes and genotypes of invasive Streptococcus pneumoniae before and after PCV10 implementation in southern Brazil.

Authors:  Juliana Caierão; Paulina Hawkins; Fernando Hayashi Sant'anna; Gabriela Rosa da Cunha; Pedro Alves d'Azevedo; Lesley McGee; Cícero Dias
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

2.  Use of Multiplex Quantitative PCR To Evaluate the Impact of Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Colonization in African Children.

Authors:  Courtney P Olwagen; Peter V Adrian; Marta C Nunes; Michelle J Groome; Mark F Cotton; Avy Violari; Shabir A Madhi
Journal:  mSphere       Date:  2017-11-08       Impact factor: 4.389

3.  Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel.

Authors:  Assaf Rokney; Shalom Ben-Shimol; Zinaida Korenman; Nurith Porat; Zeev Gorodnitzky; Noga Givon-Lavi; Merav Ron; Vered Agmon; Ron Dagan; Lea Valinsky
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

4.  Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi.

Authors:  Chrispin Chaguza; Jennifer E Cornick; Cheryl P Andam; Rebecca A Gladstone; Maaike Alaerts; Patrick Musicha; Chikondi Peno; Naor Bar-Zeev; Arox W Kamng'ona; Anmol M Kiran; Chisomo L Msefula; Lesley McGee; Robert F Breiman; Aras Kadioglu; Neil French; Robert S Heyderman; William P Hanage; Stephen D Bentley; Dean B Everett
Journal:  Vaccine       Date:  2017-07-12       Impact factor: 3.641

5.  Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan.

Authors:  Reiko Shimbashi; Bin Chang; Yoshinari Tanabe; Hiroaki Takeda; Hiroshi Watanabe; Tetsuya Kubota; Kei Kasahara; Kengo Oshima; Junichiro Nishi; Takaya Maruyama; Koji Kuronuma; Jiro Fujita; Tatsuki Ikuse; Yuki Kinjo; Motoi Suzuki; Anusak Kerdsin; Tomoe Shimada; Munehisa Fukusumi; Keiko Tanaka-Taya; Tamano Matsui; Tomimasa Sunagawa; Makoto Ohnishi; Kazunori Oishi
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

Review 6.  Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic review.

Authors:  Paul N Zivich; John D Grabenstein; Sylvia I Becker-Dreps; David J Weber
Journal:  Pneumonia (Nathan)       Date:  2018-11-05

7.  Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.

Authors:  Stephanie W Lo; Rebecca A Gladstone; Andries J van Tonder; John A Lees; Mignon du Plessis; Rachel Benisty; Noga Givon-Lavi; Paulina A Hawkins; Jennifer E Cornick; Brenda Kwambana-Adams; Pierra Y Law; Pak Leung Ho; Martin Antonio; Dean B Everett; Ron Dagan; Anne von Gottberg; Keith P Klugman; Lesley McGee; Robert F Breiman; Stephen D Bentley
Journal:  Lancet Infect Dis       Date:  2019-06-10       Impact factor: 71.421

8.  Declines in Pediatric Bacterial Meningitis in the Republic of Benin Following Introduction of Pneumococcal Conjugate Vaccine: Epidemiological and Etiological Findings, 2011-2016.

Authors:  Joseph Agossou; Chinelo Ebruke; Alphonse Noudamadjo; Julien D Adédémy; Eric Y Dènon; Honoré S Bankolé; Mariam A Dogo; Rolande Assogba; Moussa Alassane; Abdoullah Condé; Falilatou Agbeille Mohamed; Gérard Kpanidja; Moutawakilou Gomina; François Hounsou; Basile G Aouanou; Catherine Okoi; Claire Oluwalana; Archibald Worwui; Peter S Ndow; Jean Nounagnon; Jason M Mwenda; Rock A Sossou; Brenda A Kwambana-Adams; Martin Antonio
Journal:  Clin Infect Dis       Date:  2019-09-05       Impact factor: 9.079

9.  Outbreak of invasive pneumococcal disease among shipyard workers, Turku, Finland, May to November 2019.

Authors:  Marius Linkevicius; Veronica Cristea; Lotta Siira; Henna Mäkelä; Maija Toropainen; Marjaana Pitkäpaasi; Timothee Dub; Hanna Nohynek; Taneli Puumalainen; Esa Rintala; Merja E Laaksonen; Thijs Feuth; Juha O Grönroos; Jutta Peltoniemi; Heikki Frilander; Irmeli Lindström; Jussi Sane
Journal:  Euro Surveill       Date:  2019-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.